Speedbooting 2022 Investors Annual Meet-up
We express our sincere gratitude to all who took part in our annual investor meeting, where the spirit of collaboration and shared vision was palpable. From discussions ranging from preventive health to women’s health topics such as menopause and the importance of blood markers for early diagnosis, the day illuminated the depth of our commitment to transforming healthcare.
Marina Miteva, a venture building partner at KRING, highlighted the challenges and necessity for innovation in the women’s health space, particularly focusing on menopause—an area within this realm that remains largely unexplored. She urges prospective co-founders who embody a commitment to women’s health to apply for available roles. As Chief Product Officer (CPO), you’ll utilize scientific insights to develop outstanding products, while as Chief Commercial Officer (CCO), you’ll spearhead our brand’s strategic growth and pioneering marketing endeavors.
A notable milestone celebrated during the meeting was the spinout announcement of our portfolio company, aescolab. Aescolab’s mission is to empower individuals to identify the root causes of their health issues and regain control through accessible and affordable high-quality biomarker testing, an automated interpretation of results, and personalized recommendations.
KRING’s Value Addition:
“Partnering with KRING has been instrumental in leveraging a repertoire of established best practices and frameworks. Through our collaboration with KRING, we have systematically de-risked our initial business idea, enabling us to navigate the challenges with confidence. KRING’s support has proven invaluable, particularly in providing detailed market insights and refining our precise value proposition.” – Aescolab Team
Reflecting on the enriching conversations, it’s clear that our collective focus on these vital areas is not only timely but essential for enhancing global healthcare outcomes. The profound knowledge exhibited by our founders and the insights imparted by our esteemed speakers underscore the urgency and necessity of addressing these challenges with innovation.
Looking ahead, we are more determined than ever to harness the power of collaboration and advance our mission to redefine healthcare. Together, we will continue to push boundaries, leveraging cutting-edge technologies and innovative approaches to make healthcare more accessible, effective, and personalized for all.
Once again, heartfelt thanks to all who contributed to the success of our annual investor meeting. Your passion, expertise, and unwavering support propel our ongoing progress and success.
We eagerly anticipate the journey ahead, confident that, united, we will achieve our shared objectives.
